HealthyDISCONCT07042191
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
A study testing Disco (Discussion of Cost) Provider Companion Intervention in people with Healthy and Financial Toxicity, run by Barbara Ann Karmanos Cancer Institute at 1 site in United States.
Trial summary
The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this intervention could be a companion intervention for Cancer providers in combination with the already in testing DISCO app… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Healthy, Financial Toxicity
- What is being tested?
- Disco (Discussion of Cost) Provider Companion Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Dec 2022to Jul 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Oncology care providers at Karmanos Cancer Institute (KCI)/Wayne State University(WSU) including medical oncologists, nurses, social workers and advance practice providers who treat cancer patients at KCI Detroit or Farmington Hills clinics
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: DISCO Provider: A Multi-level Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this intervention could be a companion intervention for Cancer providers in combination with the already in testing DISCO app (Discussions of Cost App) for patients. Participants will:
- complete a baseline survey
- attend two one on one meetings, one as part of the development and the second as part of the pilot testing of the intervention.
Read the detailed description
20 Wayne State University (WSU)/Karmanos Cancer Institute (KCI) oncology care providers (e.g., medical oncologists, nurses, social workers, APP) who treat patients at the KCI Detroit and Farmington Hills clinics where patients are treated for cancer will be recruited. At least two providers from each discipline who treat various cancer types will be included. The study will be discussed at clinic program meetings and then interested providers will be consented. Providers who consent will agree to 1) complete a baseline survey, and 2) attend two one-on-one meetings, one as a part of the DISCO (Discussion of Cost) Provider development (Aim 1) and the second as a part of the DISCO Provider pilot-testing (Aim 2).
To achieve Aim 1, participants will be asked to complete a survey eliciting their demographic and professional characteristics prior to interviews. Then, during one-on-one interviews, which will be audio recorded and subsequently transcribed, the investigators will present the DISCO Provider wireframes and ask participants to provide feedback on the planned content, organization, and implementation. The Investigators will also present participants with strategies identified from research on how to initiate, respond to, and effectively discuss cost concerns. Investigators will ask participants about ideas for website design and training intervention implementation. Participants will be asked to complete a needs assessment interview about their use of digital support tools.
To achieve Aim 2 and pilot test DISCO Provider, participants will again meet one-on-one with the Investigators. Investigators will ask participants to provide feedback on the acceptability and usability of the working version of DISCO Provider, whether participants think it is useful for training providers to discuss cost, if the strategies suggested will likely be effective, and suggestions for improvement. Meetings will be audio recorded, transcribed, and analyzed using similar methods as those in Aim 1
- Conditions
- Healthy, Financial Toxicity
- Being tested
- Disco (Discussion of Cost) Provider Companion Intervention
- Medical subject headings
- Financial Stress
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Disco (Discussion of Cost) Provider Companion InterventionBehavioural
A communication intervention for providers to assess financial toxicity in Cancer patients
| Study group | Role | What they receive |
|---|---|---|
| DISCO (Discussions of Cost) Provider Companion Intervention | Experimental | Providers of Cancer patients at Karmanos Cancer Institute will use the DISCO (Discussion of Cost) provider communication intervention to assess its feasibility, acceptability, and usability Receives: Behavioral: Disco (Discussion of Cost) Provider Companion Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability - Qualitative report
Success of intervention measured by semi-structured qualitative interview method which addresses acceptability
Measured: Immediately Post Pilot Test
Usability-Qualitative Report
Success of intervention measured by semi-structured qualitative interview method which addresses usability
Measured: Immediately post pilot test
Usefulness-Qualitative Report
Success of intervention measured by semi-structured qualitative interview method which addresses usefulness
Measured: Immediately Post Pilot Test
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jun 2025
- Study start9 Dec 2022
- Primary completionJul 2027 (estimated)
- Study completionJul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lauren Hamel, Barbara Ann Karmanos Cancer Institute
- Investigators
- Lauren M Hamel, PhD, Principal investigator, Wayne State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07042191
- Sponsor's protocol ID
- 2022-085
- Acronym
- DISCO
- Status last verified
- Jul 2026
- First submitted
- 23 May 2025
- Last updated
- 6 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No